ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 78 | 66 | 2,770 | 1,747 | 228 |
| Gross Profit | 78 | 66 | 2,770 | 1,747 | 228 |
| Operating Expenses | 12,345 | 6,111 | 6,645 | 4,533 | 3,665 |
| Operating Income | -12,267 | -6,046 | -3,875 | -2,786 | -3,437 |
| Other Income | 250 | 87 | 64 | 174 | 0 |
| Pre-tax Income | -12,016 | -5,959 | -3,811 | -2,611 | -3,437 |
| Net Income Continuous | -12,016 | -5,959 | -3,811 | -2,611 | -3,437 |
| Net Income | $-12,016 | $-5,959 | $-3,811 | $-2,611 | $-3,437 |
| EPS Basic Total Ops | -25.19 | -19.43 | -18.35 | -14.39 | -21.59 |
| EPS Basic Continuous Ops | -25.22 | -19.43 | -18.28 | -14.49 | -21.50 |
| EPS Diluted Total Ops | -25.19 | -19.43 | -18.35 | -14.39 | -21.59 |
| EPS Diluted Continuous Ops | -25.22 | -19.43 | -18.28 | -14.49 | -21.50 |
| EBITDA(a) | $-12,165 | $-5,953 | $-3,782 | $-2,693 | $-3,339 |